Artificial Ecology Sink as prophylaxis against viral infection
Artificial Ecology Sink as prophylaxis against viral infection
批准号:
9348755
负责人:
Zhilei Chen
金额:
$222.75万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2022-06-30
关键词:
AntibodiesAreaCaringCellsChikungunya virusCulicidaeDengue VirusEcologyExtinction (Psychology)Focal InfectionFoundationsFrequenciesGenerationsGoalsHIVHabitatsHealthHumanHuman ResourcesImmuneImmune systemInfusion proceduresIntravenous infusion proceduresOrgan TransplantationOrganismPatientsPopulationPopulation GrowthPregnancy TrimestersProphylactic treatmentProtein EngineeringProteinsSalivaSourceT-LymphocyteVaccinesViralVirus DiseasesWomanZika Virusbasegene therapyimmunological statuspandemic diseasepathogenpublic health relevancetheoriesvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The overall goal of the project is to create a protein-based viral prophylaxis (PVP) that will provide short-term
(~2-3 months) protection against various viral infection following each intravenous infusion. This PVP approach
is inspired by the ecological source-sink theory which states that the population of an organism in a landscape
is controlled by the frequency of habitats that either support (source) or do not support (sink) its population
growth. A population will decline towards extinction when the fraction of sink habitats in a landscape exceeds a
threshold frequency. According to this source-sink theory, the spread of viral infection in the body, from a limited
local infection (e.g. cells directly contacting the saliva of an infected mosquito), is largely contributed by the
below the threshold amount of sink cells (sink habitats) in the body (landscape). The central hypothesis of the
project is that the introduction of viral ‘sink’ cells in the body can act as prophylaxis against the viral infection. In
this project, I proposed to convert host cells into artificial viral sinks by functionalizing them with PVP. The
duration of protection (2-3 months), although much shorter than that of a vaccine, will confer adequate
protection in many scenarios, such as women in the 1st trimester of pregnancy, travelers to pandemic areas,
and personnel taking care of infected patients. Longer protection from PVP can be achieved through repeated
infusion or gene therapy. In this project, I will engineer PVP against Zika virus. Successful completion of this
project will lay the foundation of a new generation of prophylaxis against many pathogens, especially those with
proven difficulty to vaccine development, such as HIV and dengue virus. In addition, unlike conventional
vaccines, which rely on the host immune system to produce the protective antibody and/or T cells, and are often
less effective among people with weakened immune system (very old and very young, immune compromised
due to HIV, organ transplantation, etc.), PVP will provide similar levels of protection to anyone regardless of the
health of their immune system due to the unique protective mechanism employed by PVP.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Oral Protein Therapeutics Against C. difficile Associated Colitis
-
批准号:10455793
-
项目类别:
-
资助金额:$74.77万
-
财政年份:2021
-
负责人:Zhilei Chen
-
依托单位:
A Novel Technology for Engineering Binders to Membrane Proteins
-
批准号:10040547
-
项目类别:
-
资助金额:$22.71万
-
财政年份:2020
-
负责人:Zhilei Chen
-
依托单位:
A Novel Technology for Engineering Binders to Membrane Proteins
-
批准号:10227122
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2020
-
负责人:Zhilei Chen
-
依托单位:
Internal Toxin Neutralizer for Treating STEC-infection
-
批准号:9886184
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2019
-
负责人:Zhilei Chen
-
依托单位:
Broadly neutralizing non-antibody protein for treating clostridium difficile infection
-
批准号:9293991
-
项目类别:
-
资助金额:$22.51万
-
财政年份:2016
-
负责人:Zhilei Chen
-
依托单位:
Broadly neutralizing non-antibody protein for treating clostridium difficile infection
-
批准号:9167525
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2016
-
负责人:Zhilei Chen
-
依托单位:
Isolation of Genetic Suppressor Elements Against Hepatitis C Virus
-
批准号:7905080
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2009
-
负责人:Zhilei Chen
-
依托单位:
Isolation of Genetic Suppressor Elements Against Hepatitis C Virus
-
批准号:7708619
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2009
-
负责人:Zhilei Chen
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: